Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
Alcohol and drug addiction are major public health problems, and existing treatments are only moderately effective. Although there has been interest for over half a century in the therapeutic use of classic hallucinogens to treat addictions, clinical research with these drugs was halted at an early stage in the early 1970s, leaving many fundamental questions unanswered. In the past two decades, clinical research on classic hallucinogens has resumed, although addiction treatment trials are only now beginning. The purpose of this paper is to provide a targeted review of the research most relevant to the therapeutic potential of hallucinogens, and to integrate this information with current thinking about addiction and recovery. On the basis of this information, we present a heuristic model which organizes a number of hypotheses that may be tested in future research. We conclude that existing evidence provides a convincing rationale for further research on the effects of classic hallucinogens in the treatment of addiction. Copyright © 2012 John Wiley & Sons, Ltd.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The varieties of religious experience: A study in human nature.
James, W. (1902) · doi:10.1037/10004-000 · Cited by 5,204
Antidepressant effects of ketamine in depressed patients
Berman, R. M., Cappiello, A., Anand, A., Oren, D. A., Heninger, G. R., Charney, D. S., & Krystal, J. H. (2000) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00230-9 · Cited by 3,856
A randomized trial of an N-methyl-D-aspartate antagonist in treatment-resistant major depression.
Zarate, C. A., Singh, J. B., Carlson, P. J., Brutsche, N. E., Ameli, R., Luckenbaugh, D. A., Charney, D. S., & Manji, H. K. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.8.856 · Cited by 3,766
Cognitive consequences of forced compliance.
Festinger, L., & Carlsmith, J. M. (1959) · The Journal of Abnormal and Social Psychology · doi:10.1037/h0041593 · Cited by 2,945
Kotov, R., Gamez, W., Schmidt, F., & Watson, D. (2010) · Psychological Bulletin · doi:10.1037/a0020327 · Cited by 2,677 · cited 2×
“[115] In another recent meta-analysis, the authors characterized the substance use disorder profile as low in Conscientiousness and Agreeableness, with relatively weak effects on Neuroticism and Extraversion.”
BackgroundThe self-medication hypothesis of addictive disorders: focus on heroin and cocaine dependence
(1985) · American Journal of Psychiatry · doi:10.1176/ajp.142.11.1259 · Cited by 2,538 · cited 1×
“Although the self-medication hypothesis([105]) is a common explanation, the actual processes accounting for this comorbidity have been elusive.”
BackgroundWhat is Motivational Interviewing?
Rollnick, S., & Miller, W. R. (1995) · Behavioural and Cognitive Psychotherapy · doi:10.1017/s135246580001643x · Cited by 1,737
Griffiths, R. R., Richards, W. A., McCann, U., & Jesse, R. (2006) · Psychopharmacology · doi:10.1007/s00213-006-0457-5 · Cited by 1,684 · cited 8×
“Participants in the psilocybin group also reported significantly increased current personal well-being or life satisfaction two months after the session when compared to the active control group.([54])”
BackgroundResultInfluentialRelations between personality and coping: A meta-analysis.
Connor-Smith, J. K., & Flachsbart, C. (2007) · Journal of Personality and Social Psychology · doi:10.1037/0022-3514.93.6.1080 · Cited by 1,453
Nichols, D. E. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2003.11.002 · Cited by 1,211
Research works printed but not linked: 142
- Grinspoon L., 1997, Psychedelic Drugs Reconsidered
- Grof S., 2008, LSD Psychotherapy
- Leuner H., 1967, The Use of LSD in Psychotherapy and Alcoholism, 101
- Buckman J., 1967, The Use of LSD in Psychotherapy and Alcoholism, 83
- Hoffer A., 1967, The Use of LSD in Psychotherapy and Alcoholism, 343
- Sherwood J. N., 1962, The psychedelic experience–a new concept in psychotherapy, J. Neuropsychiatr., 4, 69
- Unger S. M., 1963, Mescaline, Lsd, Psilocybin, and Personality‐Change ‐ a Review, Psychiatry, 26, 111, 10.1080/00332747.1963.11023344 · DOI · Paper page
- 10.1001/archpsyc.1967.01730290009002 · DOI · Paper page
- 10.1037/h0088594 · DOI
- Savage C., 1966, The effects of psychedelic (LSD) therapy on values, personality, and behavior, Int. J. Neuropsychiatry, 2, 241
- 10.1080/00221309.1969.9710481 · DOI
- Abuzzahab F. S., 1971, A review of LSD treatment in alcoholism, Int. Pharmacopsychiat., 6, 223, 10.1159/000468273 · DOI · Paper page
- 10.3109/16066359609010756 · DOI · Paper page
- 10.1080/02791072.1998.10399714 · DOI · Paper page
- 10.1093/shm/hkl039 · DOI · Paper page
- Grof S., 1973, DPT as an adjunct in psychotherapy of alcoholics, Int. Pharmacopsychiat., 8, 104, 10.1159/000467979 · DOI · Paper page
- 10.1080/02791072.1977.10472060 · DOI
- Smart R. G., 1966, A controlled study of lysergide in the treatment of alcoholism. 1. The effects on drinking behavior, Q. J. Stud. Alcohol, 27, 469, 10.15288/qjsa.1966.27.469 · DOI · Paper page
- 10.1176/ajp.126.1.59 · DOI · Paper page
- 10.1097/00005053-197002000-00003 · DOI · Paper page
- Tomsovic M., 1970, Lysergide treatment of schizophrenic and nonschizophrenic alcoholics: a controlled evaluation, Q. J. Stud. Alcohol, 31, 932, 10.15288/qjsa.1970.31.932 · DOI · Paper page
- M. W.Johnson R. R.Griffiths.Psilocybin in smoking cessation: A pilot study in118th Annual Meeting of the American Psychological Association San Diego CA 2010. · doi:10.1037/e609562010-001
- 10.1371/journal.pone.0009019 · DOI · Paper page
- 10.1016/j.bcp.2007.07.018 · DOI · Paper page
- Glennon R. A., 2009, Principles of Addiction Medicine, 215
- 10.1093/cercor/13.8.870 · DOI · Paper page
- 10.1016/j.pnpbp.2007.07.009 · DOI
- 10.1523/JNEUROSCI.1665-10.2010 · DOI · Paper page
- 10.1073/pnas.0708862105 · DOI · Paper page
- 10.1016/j.neulet.2011.01.046 · DOI · Paper page
- 10.1111/j.1471-4159.2008.05357.x · DOI · Paper page
- Vaidya V. A., 1997, 5‐HT2A receptor‐mediated regulation of brain‐derived neurotrophic factor mRNA in the hippocampus and the neocortex, J. Neurosci., 17, 2785, 10.1523/JNEUROSCI.17-08-02785.1997 · DOI · Paper page
- 10.1016/j.neubiorev.2009.11.009 · DOI · Paper page
- Buckholtz N. S., 1990, Lysergic acid diethylamide (LSD) administration selectively downregulates serotonin2 receptors in rat brain, Neuropsychopharmacol., 3, 137
- 10.1097/00005053-196312000-00007 · DOI · Paper page
- Pahnke W. N., 1971, The experimental use of psychedelic (LSD) psychotherapy, Int. Z. Klin. Pharmakol. Ther. Toxikol., 4, 446
- Stace W. T., 1960, Mysticism and Philosophy
- Pahnke W. N., 1969, Psychedelic drugs and mystical experience, Int. Psychiatry Clin., 5, 149
- 10.2307/1384454 · DOI · Paper page
- 10.1371/journal.pone.0014074 · DOI
- Roberts T. B., 1995, Religion and Psychoactive Sacraments: A Bibliographic Guide
- Kunitz S. J., 1994, Drinking Careers: A Twenty‐Five Year Study of Three Navajo Populations
- Halpern J. H., 2008, Evidence of health and safety in American members of a religion who use a hallucinogenic sacrament, Med. Sci. Monit., 14, SR15
- 10.1080/02791072.2009.10399905 · DOI · Paper page
- 10.1177/009164718301100406 · DOI · Paper page
- Pahnke W., 1963, Drugs and Mysticism: An Analysis of the Relationship between Psychedelic Drugs and the Mystical Consciousness
- 10.1016/j.jep.2005.04.022 · DOI · Paper page
- Stewart O., 1987, The Peyote Religion: A History
- Meyerhoff B., 1974, Peyote Hunt
- Lu L., 2009, Traditional Medicine in the Treatment of Drug Addiction, Am. J. Drug Alcohol Ab., 35, 11
- 10.1525/maq.2000.14.4.521 · DOI
- 10.1016/j.biopsych.2005.06.038 · DOI · Paper page
- 10.1002/jclp.20000 · DOI · Paper page
- Emrick C. D., 2004, American Psychiatric Publishing Textbook of Substance Abuse Treatment, 433
- 1981, Twelve Steps and Twelve Traditions
- Wilson B., 2000, My First Forty Years
- 10.1002/jclp.20004 · DOI · Paper page
- 10.1300/J020v21n04_02 · DOI
- 10.1300/J020v21n01_01 · DOI · Paper page
- 10.1111/j.1530-0277.2007.00499.x · DOI · Paper page
- 10.1037/0893-164X.10.2.90 · DOI · Paper page
- 10.1111/j.1530-0277.2010.01362.x · DOI · Paper page
- 10.1177/0269881108094300 · DOI · Paper page
- 10.1017/S1461145709000169 · DOI · Paper page
- Krystal J. H., 2007, Ketamine and the potential role for rapid‐acting antidepressant medications, Swiss Med. Wkly., 137, 215, 10.4414/smw.2007.11932 · DOI · Paper page
- 10.1007/s11920-007-0063-1 · DOI · Paper page
- 10.1016/j.biopsych.2008.09.029 · DOI · Paper page
- 10.1016/j.pbb.2007.10.003 · DOI
- 10.1111/j.1360-0443.2006.01423.x · DOI · Paper page
- 10.1080/02791072.1998.10399709 · DOI · Paper page
- Grant B. F., 2004, Prevalence and co‐occurrence of substance use disorders and independent mood and anxiety disorders: results from the national epidemiologic survey on alcohol and related conditions, Arch. Gen. Psychiat., 61, 10
- 10.1007/s00127-003-0597-4 · DOI · Paper page
- 10.1016/j.comppsych.2008.09.003 · DOI
- 10.1038/mp.2008.41 · DOI · Paper page
- 10.1016/S0740-5472(03)00118-1 · DOI
- 10.15288/jsad.2010.71.434 · DOI
- 10.1016/j.biopsych.2004.05.009 · DOI
- 10.1016/j.drugalcdep.2004.09.004 · DOI · Paper page
- 10.1001/jama.291.15.1887 · DOI · Paper page
- 10.1111/j.1530-0277.1996.tb05263.x · DOI
- LeMarquand D., 1994, Serotonin and alcohol intake, abuse, and dependence: findings of animal studies, Biol. Psychiatry, 36, 27
- 10.2190/DE.37.3.d · DOI · Paper page
- 10.1016/S0306-4603(98)00005-7 · DOI
- Dubey C., 2010, Five Factor correlates: A comparison of substance abusers and non‐substance abusers, J. Ind. Acad. Appl. Psychology, 36, 107
- 10.1186/1471-244X-8-22 · DOI · Paper page
- 10.1037/0022-3514.84.2.411 · doi:10.1037/0022-3514.84.2.411 · Paper page
- 10.1016/j.addbeh.2010.06.008 · DOI · Paper page
- 10.1006/jrpe.2001.2326 · DOI
- 10.1016/j.psychres.2004.07.013 · DOI
- 10.1300/J069v25n04_06 · DOI
- 10.1186/1471-244X-3-1 · DOI · Paper page
- 10.1093/alcalc/34.2.254 · DOI · Paper page
- 10.1016/j.pharmthera.2010.09.007 · DOI · Paper page
- 10.15288/jsad.2007.68.641 · DOI · Paper page
- 10.1016/j.drugalcdep.2009.03.009 · DOI · Paper page
- 10.1111/j.1465-3362.2011.00303.x · DOI · Paper page
- 10.1037/a0025204 · DOI
- Heinz A., 2008, Identifying the neural circuitry of alcohol craving and relapse vulnerability, Addit. Biol., 14, 12
- 10.1016/B978-0-12-385506-0.00010-7 · DOI
- 10.1192/bjp.bp.107.041228 · DOI
- 10.1111/j.1530-0277.2007.00390.x · DOI · Paper page
- 10.1016/S0278-5846(03)00081-2 · DOI · Paper page
- 10.1192/bjp.bp.110.084178 · DOI · Paper page
- 10.1016/j.bcp.2007.08.005 · DOI · Paper page
- Swift R. M., 1999, Medications and Alcohol Craving, Alcohol Res. Health, 23, 7
- 10.1016/j.neubiorev.2011.03.005 · DOI
- 10.1093/alcalc/34.2.244 · DOI · Paper page
- 10.1046/j.1360-0443.1995.9018712.x · DOI
- 10.1176/ajp.152.3.391 · DOI · Paper page
- 10.1111/j.1530-0277.1996.tb01686.x · DOI · Paper page
- 10.1111/j.1530-0277.2000.tb04648.x · doi:10.1111/j.1530-0277.2000.tb04648.x · Paper page
- 10.1001/archpsyc.1997.01830200024004 · DOI · Paper page
- 10.1097/00004850-199409000-00004 · DOI · Paper page
- 10.1038/clpt.1992.85 · DOI
- 10.1007/978-1-4899-1678-5_13 · DOI
- Naranjo C. A., 1991, Possible pharmacological probes for predicting and preventing relapse in treated alcoholics, Alcohol Alcohol. Suppl., 1, 523
- 10.1001/jama.284.8.963 · DOI · Paper page
- 10.1176/appi.ajp.2010.10050755 · DOI · Paper page
- 10.1007/s00213-002-1002-9 · DOI
- 10.1037/0033-295X.84.2.191 · DOI · Paper page
- Bandura A., 1994, Encyclopedia of Human Behavior, 14
- Bandura A., 2001, Self‐Efficacy: The Exercise of Control
- 10.1016/j.addbeh.2011.07.032 · DOI · Paper page
- 10.1080/00952990701653818 · DOI
- 10.15288/jsa.2006.67.562 · DOI
- DiClemente C. C., 1999, Motivation for Change and Alcoholism Treatment, Alcohol Res. Health, 23, 7
- 10.1111/1467-9280.00137 · DOI · Paper page
- 10.1037/a0017189 · DOI · Paper page
- Miller W. R., 2006, A consensus statement on defining change talk, MINT Bulletin, 13, 6
- 10.1111/j.1749-6632.1998.tb08242.x · DOI · Paper page
- 10.1177/0960327107087802 · DOI · Paper page
- 10.1111/j.1749-6632.2000.tb06677.x · DOI
- 10.1523/JNEUROSCI.17-22-08828.1997 · DOI · Paper page
- Frecska E., 2006, The adverse effects of hallucinogens from intramural perspective, Neuropsychopharmacol. Hung., 8, 189
- 10.1523/JNEUROSCI.3959-04.2005 · DOI · Paper page
- 10.1111/j.1369-1600.2010.00251.x · DOI · Paper page
- 10.1038/tp.2011.57 · DOI
- 10.1073/pnas.0711755105 · DOI · Paper page
- 10.1016/j.pharmthera.2008.12.001 · DOI · Paper page
- 10.1300/J020V09N01_09 · DOI · Paper page
- 10.1080/02791072.2007.10399860 · DOI · Paper page
- 10.1207/s15473333thp3404_7 · DOI · Paper page
Cited by
Psychedelics promote structural and functional neural plasticity
Ly, C., Greb, A. C., Cameron, L. P., Wong, J. M., Barragan, E. V., Wilson, P. C., Burbach, K. F., Soltanzadeh Zarandi, S., Sood, A., Paddy, M. R., et al. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.05.022 · Cited by 1,207
Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study
Bogenschutz, M. P., Forcehimes, A. A., Pommy, J. A., Wilcox, C. E., Barbosa, P., & Strassman, R. J. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565144 · Cited by 1,151
Self-citationPilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction
Johnson, M. W., Garcia-Romeu, A., Cosimano, M. P., & Griffiths, R. R. (2014) · Journal of Psychopharmacology · doi:10.1177/0269881114548296 · Cited by 914
“Several plausible mechanisms of hallucinogen-facilitated treatments have been proposed (Bogenschutz and Pommy, 2012; Carhart-Harris et al., 2012, 2014; Ross, 2012; Vollenweider and Kometer, 2010).”
BackgroundPsilocybin-Occasioned mystical experiences in the treatment of tobacco addiction.
Garcia-Romeu, A., Griffiths, R., & Johnson, M. (2015) · Current Drug Abuse Reviews · doi:10.2174/1874473708666150107121331 · Cited by 476
Predicting responses to psychedelics: a prospective study
Haijen, E. C. H. M., Kaelen, M., Roseman, L., Timmermann, C., Kettner, H., Russ, S., Nutt, D., Daws, R. E., Hampshire, A. D. G., Lorenz, R., et al. (2018) · Frontiers in Pharmacology · doi:10.3389/fphar.2018.00897 · Cited by 417
Metadata
- Authors
- Bogenschutz, M. P., & Pommy, J. M.
- Venue
- Drug Testing and Analysis
- Publisher
- Wiley
- Published
- 2012-07
- Volume
- 4
- Issue
- 7-8
- Pages
- 543-555
- ISSN
- 1942-7603 (ISSN-L)
- 1942-7611
- OpenAlex
- W1940682915
- Cited by
- 125
- References
- 42
- FWCI
- 8.32
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses. https://app.cochat.ai/papers/10.1002/dta.1376
- The paper
- Bogenschutz, M. P., & Pommy, J. M. (2012). Therapeutic mechanisms of classic hallucinogens in the treatment of addictions: from indirect evidence to testable hypotheses. Drug Testing and Analysis. https://doi.org/10.1002/dta.1376
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.